certificate of analysis comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-08-28. Numbers and descriptions here follow the published literature rather than marketing material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | SR9009; Stenabolic | Nickname is not a chemical name. |
| Typical analytical method | LC-MS/MS | Often with isotope-labeled internal standard. |
| Storage temperature | -20 °C | Desiccated and protected from light. |
| Solution stability | DMSO stock; avoid freeze-thaw | Store at -20 to -80 °C. |
| Regulatory status | Not approved; varies by country | May be restricted as research chemical. |
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
== Adverse effects == Adverse effects, especially with higher doses, include dizziness, drowsiness, fatigue, diarrhea, unusual dreams, trouble sleeping, depression, and vision problems such as blurred vision or dry eyes. β-blockers, including metoprolol, reduce salivary flow via inhibition of the direct sympathetic innervation of the salivary glands. Metoprolol may also cause the hands and feet to feel cold. Due to the high penetration across the blood–brain barrier, lipophilic beta blockers such as propranolol and metoprolol are more likely than other less lipophilic beta blockers to cause sleep disturbances such as insomnia, vivid dreams and nightmares. Patients should be cautious while driving or operating machinery due to its potential to cause decreased alertness. There may also be an impact on blood sugar levels, and it can potentially mask signs of low blood sugar. The safety of metoprolol during pregnancy is not fully established.
The Scottish Government had wanted it delayed until after a separate hearing into determining the definition of a woman. 6 August – Five people are arrested when protestors interrupt the Men's Elite Road Race at Falkirk. The environmental protest group This Is Rigged claims responsibility. 7 August – Police Scotland confirms that the bodies of three hillwalkers have been found after they failed to return from a trip to Aonach Eagach Ridge in Glen Coe two days earlier. Education staff at ten local authorities who belong to the Unite union vote to take rolling industrial action after rejecting a pay offer from the Scottish Government. 8 August – Jamie Starrs is sentenced to ten and a half years in prison for the rape of Amber Gibson in June 2021, five months before she was murdered by her brother. 9 August – The names of several thousand people adopted as children going back 100 years are removed from the ScotlandsPeople website amid concerns over privacy and safety. 10 August – Social Security Scotland issues an apology over a staff quiz that included pictures of child killers. The Friday Fun Quiz asked staff to identify people called Ian from images, and includes pictures of Ian Brady and Ian Huntley. 11 August – At the High Court in Stirling, James White, the leader of one of Scotland's largest organised crime gangs who was extradited from Brazil to face trial, is sentenced to ten years in prison for series organised crime and firearms offences. 12 August – Police Scotland announces plans to cut civilian staff and freeze recruitment in order to maintain officer numbers.
Gyrification The process by which the cerebral cortex develops folds (gyri) and grooves (sulci) during brain development. Gyrification increases the surface area of the brain, allowing for greater cognitive capacity within the limited volume of the skull.
Lord Advocate Dorothy Bain, Scotland's most senior lawyer, apologises to victims of the Post Office scandal, saying they were let down by the justice system. Finance Secretary Shona Robison confirms that the Scottish Government is to cut at least 1,200 funded university places as they cannot afford to continue paying for additional places created during the COVID-19 pandemic. 17 January – The UK government is seeking legal expenses from the Scottish Government over its challenge against the veto of the Gender Recognition Reform (Scotland) Bill. 18 January – Community Safety Minister Siobhian Brown announces that Scotland will introduce legislation to ban the sale, breeding and abandonment of American XL bully dogs, replicating the law for England and Wales, at a date to be confirmed later. Nuns Sister Sarah McDermott and Sister Eileen Igoe, and carer Margaret Hughes, who mistreated children at Smyllum Park, an orphanage in Lanark from 1969 until 1981 when it closed, are each sentenced to three years in prison. Helen Goss, the mother of an eleven-year-old girl from Aberdeenshire with long COVID, launches legal action against NHS Grampian for what she says are the health board's "multiple failings" in the care and treatment of her daughter. 21 January – Scotland's First Minister, Humza Yousaf, tells the BBC's Sunday with Laura Kuenssberg he is willing to work with Sir Keir Starmer if he becomes prime minister after the next general election. ScotRail cancels all services from 7pm until after the following day's rush hour because of high winds caused by Storm Isha.
Sources: en.wikipedia.org
== Species == At times in the past, taxonomists included many species in the genus Gadus (from Ancient Greek: γάδος, romanized: gádos). Most of these are now either classified in other genera or have been recognized as forms of one of three species. All these species have several common names, most of them ending with the word "cod" (see naming), whereas other species, closely related, have other common names (such as pollock and haddock). However, many other unrelated species also have common names ending in "cod". Usage often varies across localities and over time.
Cystic fibrosis (caused by the G542X mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) Beta thalassaemia (β-globin) Hurler syndrome Dravet syndrome Usher syndrome Nonsense mutations in other genes may also drive dysfunction of several tissue or organ systems: SMAD8 SMAD8 is the eighth homolog of the ENDOGLIN gene family and is involved in the signaling between TGF-b/BMP. It has been identified that novel nonsense mutations in SMAD8 are associated with pulmonary arterial hypertension. The pulmonary system relies on SMAD1, SMAD5, and SMAD 8 to regulate pulmonary vascular function. Downregulation and loss of signals that are normally operated by SMAD8 contributed to pathogenesis in pulmonary arterial hypertension. The ALK1 gene, a part of the TGF-B signaling family, was found to have been mutated while also down-regulating the SMAD8 gene in patients with pulmonary arterial hypertension. SMAD8 mutants were not phosphorylated by ALK1, disrupting interactions with SMAD4 that would normally allow for signaling in wild-type organisms.
Its ending had a mixed response, with some reviewers appreciating their ability to choose one of the game's four endings (adding an incentive to replay the game) and others considering the ending anticlimactic. GameSpot and GameSpy called the dialogue sharply written, with many memorable lines. Eurogamer noted that the characters' frequent use of vulgar language worked; written as real people, such language fit their character rather than giving the game an adult veneer. The website appreciated the breadth of dialogue options, allowing the player greater control of how to play their character. PC Zone opined that the quantity of well-written dialogue did not guarantee quality; many player choices seemed to have little effect on a conversation's outcome, and the best response was often the most obvious. The voice acting was repeatedly praised for the actors' quality and the amount of voice work, due to the many dialogue options. Much of Bloodlines' criticism focused on technical problems when it was released, undermining the game experience or making it unplayable. Several reviewers noted errors which closed the game and typographical errors in on-screen text. Others cited frequent, sometimes-lengthy load times encountered while moving between hubs and entering or exiting buildings and areas. GameSpot called the game's artificial intelligence poor, often causing enemies to rush at an armed player, fire at them from too great a distance to be effective or become immobilized while waiting for the player's next attack.
In the late 1990s, some investigators thought that the fact that symptoms emerged when antidepressants were discontinued might mean that antidepressants were causing addiction, and some used the term "withdrawal syndrome" to describe the symptoms. While people taking antidepressants do not commonly exhibit drug-seeking behavior, stopping antidepressants leads to similar symptoms as found in drug withdrawal from benzodiazepines, and other psychotropic drugs. As such, some researchers advocate the term withdrawal over discontinuation, to communicate the similar physiological dependence and negative outcomes. Due to pressure from pharmaceutical companies who make antidepressants, the term "withdrawal syndrome" is no longer used by drug makers, and thus, most doctors, due to concerns that they may be compared to other drugs more commonly associated with withdrawal.
== Baltimore Colts == The Baltimore Colts defensive line that included future Hall of Famers defensive end Gino Marchetti and tackle Art Donovan, along with end Don Joyce and tackle Eugene "Big Daddy" Lipscomb has also been referred to as the "'fearsome foursome'" by at least 1958. They have been called the prototype of defensive lines. In addition to Marchetti’s and Donovan’s Hall of Fame status, Lipscomb was first-team All-Pro in 1958 and 1959. Marchetti is considered among the greatest defensive ends in NFL history. The Colts won the 1958 and 1959 NFL championships over the New York Giants, the 1958 game being known as "The Greatest Game Ever Played". They played together as a line from 1956 to 1960, with defensive end Ordell Braase taking over as a starter for Joyce in 1960, and Lipscomb being traded to the Steelers before the start of the 1961 season.
Sources: en.wikipedia.org
As such, GGT elevations lack the necessary specificity to be a useful confirmatory test for cholestasis. Importantly, conjugated hyperbilirubinemia is present in 80% of patients with extrahepatic cholestasis and 50% of patients with intrahepatic cholestasis. Given that many patients with hyperbilirubinemia may not have cholestasis, the measurement of bilirubin levels is not a good diagnostic tool for identifying cholestasis. In a later stage of cholestasis aspartate transaminase (AST), alanine transaminase (ALT) and unconjugated bilirubin may be elevated due to hepatocyte damage as a secondary effect of cholestasis.
Recent changes in Moscow's regional climate are often cited by climate scientists as evidence of global warming, since the city is in the middle latitudes of the Northern Hemisphere; however, by definition, climate change is global, not regional. During the summer, very high temperatures are often recorded in the city (in 2001, 2002, 2003, 2010, 2011, and 2021). Along with the southern part of Central Russia, after recent years of hot summer seasons, Moscow's climate shows hot-summer classification trends. Winter has also become significantly milder: for example, the average January temperature in the early 1900s was −12.0 °C (10.4 °F), while it is currently about −7.0 °C (19.4 °F). The end of January–February is often colder, with frosts reaching −30.0 °C (−22.0 °F) a few nights per year (in 2006, 2010, 2011, 2012, and 2013). As of 2024, the most recent decade was the warmest in the history of meteorological observations of Moscow. Temperature changes in the city are shown in the table below:
This enzyme belongs to the family of oxidoreductases, specifically those acting on a sulfur group of donors with a quinone or similar compound as acceptor. The systematic name of this enzyme class is glutathione:dehydroascorbate oxidoreductase. Other names in common use include dehydroascorbic reductase, dehydroascorbic acid reductase, glutathione dehydroascorbate reductase, DHA reductase, dehydroascorbate reductase, GDOR, and glutathione:dehydroascorbic acid oxidoreductase. This enzyme participates in three metabolic pathways: ascorbate and aldarate metabolism, glutamate metabolism, and glutathione metabolism.
== Polymer-hybrid delivery systems == Coiled-coils are used as non-covalent polymer-drug conjugates to link drugs to polymer backbones. The goal of these types of systems is to attach multiple drugs to a non-toxic backbone such that drugs can be stably transported throughout the body and released at a controlled rate once at the target location. Doxorubicin, paclitaxel, and campothecin are examples of drugs typically used with polymer-drug conjugate systems. Hetero-dimeric coiled-coils motifs can be utilized in such systems, whereby one strand would be conjugated to the polymer backbone network, while the other strand would be conjugated to the drug of choice. The coiled-coils would then oligomerize, followed by the administration of the drug system into the body, whereby the stability of the coiled-coil in physiological conditions would ensure the intact delivery of the drug to the target. Upon cellular uptake at the target site, coiled-coil system would be exposed to a decrease in pH associated with the acidic environments of endosomes and lysosomes, triggering the dissociation of the coiled-coils, resulting in drug release. Dr. Harm-Anton Klok and colleagues were the first to investigate the usage of coiled coils as linkers in polymer-drug conjugate systems, whereby they utilized the parallel heterodimeric E3/K3 coiled-coil system (known for its stability at physiological pH and dissociation at pH 5, resulting in E3 homotrimers along with K3 unimers) to link cargo to a poly(N-(2-hydroxypropyl)methacrylamide) (PHPMA)-based polymer backbone. Klok et al.
== Chemistry == Teicoplanin (TARGOCID, marketed by Sanofi Aventis Ltd) is actually a mixture of several compounds, five major (named teicoplanin A2-1 through A2-5) and four minor (named teicoplanin RS-1 through RS-4). All teicoplanins share a same glycopeptide core, termed teicoplanin A3-1 — a fused ring structure to which two carbohydrates (mannose and N-acetylglucosamine) are attached. The major and minor components also contain a third carbohydrate moiety — β-D-glucosamine — and differ only by the length and conformation of a side-chain attached to it. Teicoplanin A2-4 and RS-3 have chiral side chains while all other side chains are achiral. Teicoplanin A3 lacks both the side chains as well as the β-D-glucosamine moiety. The structures of the teicoplanin core and the side-chains that characterize the five major as well as four minor teicoplanin compounds are shown below.
Sources: en.wikipedia.org
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.
Solid material is usually kept at -20 °C, desiccated, and protected from light. Dimethyl sulfoxide stocks should be stored cold and subjected to minimal freeze-thaw cycles. Aqueous solutions are generally less stable and should be prepared fresh when possible.
Legality depends on the country and the intended use. It is not an approved medicine, and some places restrict or ban sales for human consumption. Buyers should verify local rules and product documentation before procurement.
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.